Cargando…
Clinical implication of minimal residual disease assessment by next-generation sequencing-based immunoglobulin clonality assay in pediatric B-acute lymphoblastic leukemia
Measuring minimal residual disease (MRD) during treatment is valuable to identify acute lymphoblastic leukemia (ALL) patients who require intensified treatment to avert relapse. We performed the next-generation sequencing (NGS)-based immunoglobulin gene (Ig) clonality assay and evaluated its clinica...
Autores principales: | Lee, Jae Wook, Kim, Yonggoo, Ahn, Ari, Lee, Jong Mi, Yoo, Jae Won, Kim, Seongkoo, Cho, Bin, Chung, Nack-Gyun, Kim, Myungshin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9521036/ https://www.ncbi.nlm.nih.gov/pubmed/36185293 http://dx.doi.org/10.3389/fonc.2022.957743 |
Ejemplares similares
-
Spectrum of Genetic Mutations in Korean Pediatric Acute Lymphoblastic Leukemia
por: Yoo, Jae Won, et al.
Publicado: (2022) -
Discontinuation of tyrosine kinase inhibitors based on BCR-ABL1 monitoring by digital droplet PCR in pediatric chronic myeloid leukemia
por: Kim, Yeojae, et al.
Publicado: (2022) -
Rapid resolution of bone marrow necrosis mimicking relapse of pediatric acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2020) -
High incidence of RAS pathway mutations among sentinel genetic lesions of Korean pediatric BCR‐ABL1‐like acute lymphoblastic leukemia
por: Lee, Jae Wook, et al.
Publicado: (2020) -
Clonal Cell Proliferation in Paroxysmal Nocturnal Hemoglobinuria: Evaluation of PIGA Mutations and T-cell Receptor Clonality
por: Park, Joonhong, et al.
Publicado: (2019)